Australia Inks Next-Gen mRNA Technology Deal With US
Commonwealth Serum Laboratories (CSL), an Australian biotechnology company and the world’s second-biggest flu vaccine manufacturer, has agreed to pay $312 million ($US200 million) to use...
Commonwealth Serum Laboratories (CSL), an Australian biotechnology company and the world’s second-biggest flu vaccine manufacturer, has agreed to pay $312 million ($US200 million) to use...
The Tokyo Stock Exchange (TSE), operated by Japan Exchange Group Inc. (JPX), in Tokyo, Japan, on Monday, Nov. 30, 2020.Toru Hanai | Bloomberg via Getty...
Australian retail workers are being left behind as rapid shifts in technology reshape the industry, a new study has found. Retail workers, who make up...